Anatomic Pathology Market by Product & Service (Instruments (Tissue Processors, Microtome), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal, Lung)), End User, Region - Global Forecasts to 2025
[306 Pages Report] The global anatomic pathology market size is estimated to grow from USD 33.3 billion in 2020 to USD 46.8 billion by 2025, at a CAGR of 7.1%. The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent during the forecast period.
COVID-19 Impact on Anatomic Pathology Market
Globally, the COVID-19 outbreak has impacted every aspect of the diagnostics industry, including the anatomic pathology market. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals.
After commencing cancer surgeries or other surgeries, surgeons run through a series of pathology tests to decide the best treatment for patients. However, due to the lockdown in Q2 of many countries, elective and cancer surgeries have reduced significantly. For instance, according to the World Economic Forum, 28 million elective surgeries and 38% of global cancer surgeries have been delayed or postponed in Q2. As a result, the number of diagnostic tests has reduced. This has further reduced the sales of anatomic pathology products during the Q2 2020. Moreover, due to the robust increase in the incidence of COVID- 19, pathology laboratories are now prioritizing and focusing on COVID-19 tests.
Currently, many countries are now undergoing lockdown relaxations, and most hospitals have resumed elective surgeries. As a result, the number of diagnostic tests conducted is now increasing. Owing to the factors mentioned above, the overall growth rate of the anatomic pathology market is less when compared to the previous year.
Global Anatomic Pathology Market Dynamics
Driver: high incidence of cancer and other targeted diseases
Cancer is a complex disease that develops through the multi-stage carcinogenesis process involving multiple pathways. As a result, there are various hurdles associated with cancer diagnosis, prognosis, and therapy. Histopathology is the microscopic study of diseased tissue. It is a vital part of anatomic pathology since the accurate diagnosis of cancer and other diseases usually requires the histopathological examination of samples. This is an important indicator of market growth due to the rising prevalence and incidence of cancer globally.
Due to the increasing incidence of cancer, the demand for oncology diagnostics has increased significantly. This has compelled government organizations as well as healthcare providers and institutions to support disease diagnosis and treatment efforts.
OPPORTUNITY: Emerging Markets
Developing countries such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for players operating in the anatomic pathology market. The huge population base, especially in India and China, offers a sustainable market for anatomic pathology. Lifestyle changes and poor diets in these regions have resulted in an increase in the prevalence of chronic diseases such as cancer, CVDs, and autoimmune diseases. According to the World Bank, in 2016, the mortality rate for diabetes, CVDs, and cancer in individuals aged between 30 and 70 years in emerging countries, such as China (17.0%), India (23.3%), South Africa (26.2%), and Brazil (16.6%), was higher than that of developed countries such as Germany (12.1%), Canada (9.8%), the US (14.6%), and France (10.6%). The higher cancer mortality can be attributed to the undiagnosed cancer population, the insufficient number of diagnostic laboratories, and the inadequate number of histopathologists.
The R&D expenditure in Asia was estimated at USD 955 billion in 2018, which accounted for a share of 43.6% of the global R&D expenditure. China’s R&D investments increased by 6.7% to USD 475 billion in 2018 (Source: R&D Magazine, 2018). This factor is indicative of the high growth potential of emerging markets. As a result, a number of players in the anatomic pathology market are focusing on expanding their geographic presence by setting up new R&D and manufacturing facilities in developing countries.
Challenges: Lack of skilled professionals
The demand for pathology services has increased significantly for clinical applications due to the increasing prevalence of cancer. Histopathology technologies account for more than 80% of the tests performed on cancer patients. However, there is a dearth of trained staff in these laboratories. A large number of histopathologists have reached retirement age, and fewer histopathologists are being trained. On the other hand, laboratories are under pressure to process an increasing number of specimens with limited staff. This is expected to hamper the growth of the anatomic pathology market.
NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
|
Country |
Number of Pathologists (Approximate) |
|
US |
4 |
|
Canada |
5 |
|
Sweden |
2 |
|
UK |
7 |
|
Netherlands |
7 |
Trends: Reagent rental agreements
Reagent rental agreements are sales agreements between end-users such as hospitals or diagnostic laboratories and manufacturers of anatomic pathology products. Under these agreements, the end-user rents or purchases instruments at a subsidized rate by entering into a reagent purchase contract with the manufacturer. This mutually beneficial agreement lowers the initial capital investment for the end-user while assuring the manufacturer of guaranteed purchases over a substantial period of time. In some cases, instruments are rented out to the end-user at a cost-per-test rate.
Reagent rental agreements and cost-per-test contracts provide large benefits for clinical laboratories trying to reduce costs. They also help laboratories avoid major fixed capital expenditures associated with the purchase of new equipment. For high-volume laboratories, these expenditures are substantially higher than those of a regular laboratory. Moreover, with the average contract lasting between five and ten years, this allows laboratories to remain updated with the latest innovations in diagnostics. As the contract expires, laboratories can replace older analyzers with newer ones. Some contracts also include service/maintenance expenses in the cost, providing additional savings for laboratories.
Services segment to witness the highest growth during the forecast period
By product & service, the anatomic pathology market is segmented into services, instruments, and consumables. The services segment accounted for the largest market share in 2019 and is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.
Disease diagnosis segment accounted for the largest share of the anatomic pathology market, by application, in 2019
Based on the application, the anatomic pathology market is segmented into disease diagnosis and medical research. The market for disease diagnosis is further segmented into cancer and other diseases. In 2019, the disease diagnosis segment accounted for the largest market share. This can be attributed to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.
North America is the largest market for anatomic pathology
Based on the region, the global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the anatomic pathology market in North America.
Key Market Players
Prominent players in the anatomic pathology market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), PHP Holdings Corporation (Japan), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).
Hoffmann-La Roche Ltd. (Switzerland) is the leading player in the anatomic pathology market. The company offers a full range of consumables that are used for the diagnosis of various types of diseases, including cancers of the lung, breast, and blood. The company focuses on organic growth strategies to maintain its leading position in the market. For instance, in 2018, the company received CE approval for its BenchMark ULTRA Plus Staining System. Similarly, in April 2017, the company received FDA approval for its CINtec Histology test.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2016–2025 |
|
Base year considered |
2019 |
|
Forecast period |
2020–2025 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product & service, application, end user, and region |
|
Geographies covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Companies covered |
F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHP Holdings Corporation (Japan), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US). |
This report categorizes the anatomic pathology market into the following segments and subsegments:
By Product & Service
- Services
- Histopathology
- Cytopathology
- Instruments
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- Microtomes
- Embedded Systems
- Coverslippers
- Other Instruments (Slide Labelers, Grossing Stations, and Paraffin Dispensers)
- Consumables
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Kits & Reagents
- Stains & Solvents
- Fixatives
- Other Kits & Reagents (Blocking Sera, Chromogenic Substrates, Stabilizers, and Diluents)
- Probes
- Other Consumables (Microtome Blades, Slides, Coverslips, and Cassettes)
- Antibodies
By Application
- Disease Diagnosis
- Cancer
- Breast Cancer
- Lung Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Other Cancers (Includes Cancers of the Bone, Thyroid, Cervix, Skin, Lymphoma, Gallbladder Carcinoma, Renal Cell Carcinoma, and Pleomorphic Sarcoma)
- Other Diseases (Includes HBV, Epstein-Barr Virus, Liver Diseases, Muscular Dystrophy, and Gastroesophageal Reflux Disease)
- Medical Research
By End-User
- Hospital Laboratories
- Clinical Laboratories
- Other End Users
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Recent Developments
- In March 2020, Sakura Finetek Launched four new ready-to-use antibodies for the Tissue-Tek Genie Advanced Staining System
- In September 2018, Sakura Finetek launched the Accu-Cut SRM 300 LT Manual Microtome.
- In 2018, F. Hoffmann-La Roche received the CE approval for its BenchMark ULTRA Plus Staining System.
- In March 2016, BD received FDA approval for its new automated cervical cancer screening systems, BD Totalys MultiProcessor and BD Totalys SlidePrep instruments
Frequently Asked Questions (FAQ):
What is the projected market value of the global anatomic pathology market?
The global market of anatomic pathology is projected to reach USD 46.8 billion by 2025.
What is the estimated growth rate (CAGR) of the global anatomic pathology market for the next five years?
The global anatomic pathology market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.1% from 2020 to 2025.
Who are the major players offering anatomic pathology market products in the market?
F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHP Holdings Corporation (Japan), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).
Which region is lucrative for the anatomic pathology market?
Asia Pacific region provides significant growth opportunities for the players operating in the market. This is mainly due to the presence of a large patient pool, and increasing prevalence of cancer & other infectious diseases.
Which product & services segment accounted for the largest share in 2019?
The anatomic pathology market is segmented into services, consumables, and instruments. Among all, the services segment accounted for the largest share in 2019. This is mainly due to the increasing incidences of cancer across the globe. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 ANATOMIC PATHOLOGY MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Bottom-up approach for the instruments and consumables market
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.2.2.1 Services market estimation based on number of tests
2.2.2.2 Services market estimation based on procedures
2.2.3 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 7 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 10 ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 11 ANATOMIC PATHOLOGY MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 12 ANATOMIC PATHOLOGY MARKET, BY REGION
4 PREMIUM INSIGHTS
4.1 ANATOMIC PATHOLOGY: MARKET OVERVIEW
FIGURE 13 HIGH INCIDENCE OF CANCER & OTHER TARGET DISEASES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE
FIGURE 14 SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN ANATOMIC PATHOLOGY MARKET IN 2019
4.3 GEOGRAPHICAL SNAPSHOT OF THE ANATOMIC PATHOLOGY MARKET
FIGURE 15 COUNTRIES IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 ANATOMIC PATHOLOGY MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 High incidence of cancer and other target diseases
TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
5.2.1.2 Recommendations for cancer screening
5.2.1.3 Availability of reimbursement
5.2.1.4 Growing focus on personalized medicine
TABLE 2 % OF PERSONALIZED MEDICINES IN OVERALL DRUG APPROVAL BY FDA, 2014 TO 2019
5.2.2 OPPORTUNITIES
5.2.2.1 Increasing number of clinical trials pertaining to cancer drugs
FIGURE 17 NUMBER OF ARTICLES RELATED TO HISTOPATHOLOGY PUBLISHED ON PUBMED (2010-2019)
5.2.2.2 Emerging economies
5.2.3 CHALLENGES
5.2.3.1 Availability of refurbished products
5.2.3.2 Lack of skilled professionals
TABLE 3 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
5.2.3.3 Product failures and recalls
5.2.4 TRENDS
5.2.4.1 Reagent rental agreements
5.2.5 IMPACT OF COVID-19 ON THE ANATOMIC PATHOLOGY MARKET
6 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
FIGURE 18 SERVICES TO CONTINUE TO DOMINATE THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD
TABLE 4 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 5 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 73
6.2 SERVICES
TABLE 6 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 7 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
6.2.1 HISTOPATHOLOGY
6.2.1.1 The majority of cancers diagnosed are via histopathology- a key factor driving market growth
TABLE 8 HISTOPATHOLOGY SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 9 HISTOPATHOLOGY SERVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.2.2 CYTOPATHOLOGY
6.2.2.1 Government focus on cervical cancer screening has boosted the growth of the cytopathology services market
TABLE 10 CYTOPATHOLOGY SERVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 11 CYTOPATHOLOGY SERVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.3 CONSUMABLES
TABLE 12 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 13 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
6.3.1 ANTIBODIES
TABLE 14 ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 15 ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
6.3.1.1 Primary antibodies
6.3.1.1.1 North America dominates the primary antibodies market
TABLE 16 PRIMARY ANTIBODIES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 17 PRIMARY ANTIBODIES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.3.1.2 Secondary antibodies
6.3.1.2.1 The Asia Pacific region is projected to reach the highest growth for secondary antibodies
TABLE 18 SECONDARY ANTIBODIES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 19 SECONDARY ANTIBODIES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.3.2 KITS & REAGENTS
TABLE 20 KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 21 KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
6.3.2.1 Stains & solvents
6.3.2.1.1 North America accounted for the highest share in this market
TABLE 22 STAINS & SOLVENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 23 STAINS & SOLVENTS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.3.2.2 Fixatives
6.3.2.2.1 North America accounts for the largest share of the fixatives market
TABLE 24 FIXATIVES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 25 FIXATIVES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.3.2.3 Other kits & reagents
TABLE 26 OTHER KITS & REAGENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 27 OTHER KITS & REAGENTS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.3.3 PROBES
6.3.3.1 APAC is expected to show the highest growth in the probes market
TABLE 28 PROBES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 29 PROBES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.3.4 OTHER CONSUMABLES
TABLE 30 OTHER CONSUMABLES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 31 OTHER CONSUMABLES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.4 INSTRUMENTS
TABLE 32 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2029 (USD MILLION)
TABLE 33 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY REGION, 2020-2025 (USD MILLION) 86
6.4.1 SLIDE STAINING SYSTEMS
6.4.1.1 Availability of automated systems will drive market growth during the forecast period
TABLE 34 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 35 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.4.2 TISSUE PROCESSING SYSTEMS
6.4.2.1 Rising adoption of automation is a key trend in the tissue processing systems market
TABLE 36 TISSUE PROCESSING SYSTEMS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 37 TISSUE PROCESSING SYSTEMS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.4.3 CELL PROCESSORS
6.4.3.1 Cell processors are used to remove unwanted matter in samples-making them important instruments in the market
TABLE 38 CELL PROCESSORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 39 CELL PROCESSORS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.4.4 MICROTOMES
6.4.4.1 North America accounts for the largest share of the microtomes market
TABLE 40 MICROTOMES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 41 MICROTOMES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.4.5 EMBEDDING SYSTEMS
6.4.5.1 The Asia Pacific region is expected to register the highest growth during the forecast period for this segment
TABLE 42 EMBEDDING SYSTEMS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 43 EMBEDDING SYSTEMS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.4.6 COVERSLIPPERS
6.4.6.1 Coverslippers are widely used instruments in research alongside staining systems
TABLE 44 COVERSLIPPERS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 45 COVERSLIPPERS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.4.7 OTHER INSTRUMENTS
TABLE 46 OTHER INSTRUMENTS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 47 OTHER INSTRUMENTS MARKET, BY REGION, 2020-2025 (USD MILLION)
7 ANATOMIC PATHOLOGY MARKET, BY APPLICATION
7.1 INTRODUCTION
FIGURE 19 DISEASE DIAGNOSTICS APPLICATIONS TO CONTINUE TO DOMINATE THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD
TABLE 48 ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 49 ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
7.2 DISEASE DIAGNOSTICS
TABLE 50 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2016-2019 (USD MILLION)
TABLE 51 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2020-2025 (USD MILLION)
7.2.1 CANCER
TABLE 52 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 53 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
7.2.1.1 Breast cancer
7.2.1.1.1 Breast cancer holds the highest mortality rate among cancers in North America
TABLE 54 BREAST CANCER INCIDENCE, BY REGION, 2018 VS. 2025
TABLE 55 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION, 2016-2019 (USD MILLION)
TABLE 56 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION, 2020-2025 (USD MILLION)
7.2.1.2 Gastrointestinal cancer
7.2.1.2.1 North America accounts for the largest share of the anatomic pathology market for gastrointestinal cancer
TABLE 57 STOMACH CANCER INCIDENCE, BY REGION, 2018 VS. 2025
TABLE 58 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2016-2019 (USD MILLION)
TABLE 59 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2020-2025 (USD MILLION)
7.2.1.3 Lung cancer
7.2.1.3.1 Lung cancer is the most common cancer in the world
TABLE 60 LUNG CANCER INCIDENCE, BY REGION, 2018 VS. 2025
TABLE 61 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION, 2016-2019 (USD MILLION)
TABLE 62 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION, 2020-2025 (USD MILLION)
7.2.1.4 Prostate cancer
7.2.1.4.1 Prostate cancer is the third-leading cause of death in North America
TABLE 63 PROSTATE CANCER INCIDENCE, BY REGION, 2018 VS. 2025
TABLE 64 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2016-2019 (USD MILLION)
TABLE 65 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2020-2025 (USD MILLION)
7.2.1.5 Other cancers
TABLE 66 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCER, BY REGION, 2016-2019 (USD MILLION)
TABLE 67 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCER, BY REGION, 2020-2025 (USD MILLION)
7.2.2 OTHER DISEASES
TABLE 68 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2016-2019 (USD MILLION)
TABLE 69 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2020-2025 (USD MILLION)
7.3 MEDICAL RESEARCH
7.3.1 GROWING RESEARCH ACTIVITIES WILL DRIVE THE ADOPTION OF ANATOMIC PATHOLOGY PRODUCTS IN THIS APPLICATION SEGMENT
TABLE 70 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2016-2019 (USD MILLION)
TABLE 71 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2020-2025 (USD MILLION)
8 ANATOMIC PATHOLOGY MARKET, BY END USER
8.1 INTRODUCTION
FIGURE 20 HOSPITAL LABORATORIES TO DOMINATE THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD
TABLE 72 ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 73 ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
8.2 HOSPITAL LABORATORIES
8.2.1 HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
TABLE 74 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2016-2019 (USD MILLION)
TABLE 75 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2020-2025 (USD MILLION)
8.3 CLINICAL LABORATORIES
8.3.1 INCREASING OUTPATIENT SURGERIES TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 76 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016-2019 (USD MILLION)
TABLE 77 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020-2025 (USD MILLION)
8.4 OTHER END USERS
TABLE 78 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION, 2016-2019 (USD MILLION)
TABLE 79 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION, 2020-2025 (USD MILLION)
9 ANATOMIC PATHOLOGY MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 21 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ANATOMIC PATHOLOGY MARKET IN 2025
TABLE 80 ANATOMIC PATHOLOGY MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 81 ANATOMIC PATHOLOGY MARKET, BY REGION, 2020-2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT
TABLE 82 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 83 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 84 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 85 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 86 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 87 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 88 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 89 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 90 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 91 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 92 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 93 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 94 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 95 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 96 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 97 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 98 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 99 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 100 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 101 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 102 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 103 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the global anatomic pathology market
TABLE 104 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 105 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 106 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 107 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 108 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 109 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 110 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 111 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 112 US: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 113 US: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 114 US: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 115 US: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 116 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 117 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 118 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 119 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 120 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 121 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 122 US: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 123 US: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
FIGURE 23 US: CANCER STATISTICS
9.2.2 CANADA
9.2.2.1 High burden of cancer to support market growth
FIGURE 24 CANADA: CANCER STATISTICS
TABLE 124 CANADA: KEY MACROINDICATORS
TABLE 125 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 126 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 127 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 128 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 129 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 130 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 131 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 132 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 133 CANADA: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 134 CANADA: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 135 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 136 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 137 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 138 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 139 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 140 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 141 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 142 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 143 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 144 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3 EUROPE
TABLE 145 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 146 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 147 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 148 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 149 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 150 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 151 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE
TABLE 152 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 153 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 154 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 155 EUROPE: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 156 EUROPE: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 157 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 158 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 159 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 160 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 161 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 162 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 163 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 164 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 165 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 166 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Availability of reimbursement for colorectal cancer screening to support market growth
TABLE 167 INCIDENCE OF CANCER, BY TYPE, 2018 VS. 2025
TABLE 168 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 169 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 170 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 171 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 172 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 173 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 174 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 175 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 176 GERMANY: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 177 GERMANY: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 178 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 179 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 180 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 181 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 182 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 183 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 184 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 185 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 186 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 187 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Government funding for cancer diagnosis & prevention to support market growth
TABLE 188 CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
TABLE 189 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 190 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 191 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 192 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION
TABLE 193 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 194 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 195 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 196 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 197 FRANCE: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 198 FRANCE: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 199 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 200 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 201 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 202 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 203 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 204 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 205 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 206 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 207 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 208 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.3 UK
9.3.3.1 Government initiatives to drive market growth in the UK
TABLE 209 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 210 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 211 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 212 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 213 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 214 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 215 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 216 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 217 UK: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 218 UK: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 219 UK: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 220 UK: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 221 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 222 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 223 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 224 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 225 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 226 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 227 UK: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 228 UK: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 High incidence of cancer and increasing per capita healthcare spending to support market growth in Italy
TABLE 229 INCIDENCE OF CANCER, BY TYPE, 2018 VS. 2025
TABLE 230 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 231 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 232 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 233 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 234 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 235 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 236 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 237 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 238 ITALY: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 239 ITALY: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 240 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 241 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 242 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 243 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 244 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 245 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 246 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 247 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 248 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 249 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 High incidence of chronic diseases to drive the Spanish market
TABLE 250 SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 251 SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 252 SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 253 SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 254 SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 255 SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 256 SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 257 SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 258 SPAIN: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 259 SPAIN: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 260 SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 261 SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 262 SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 263 SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 264 SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 265 SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 266 SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 267 SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 268 SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 269 SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 270 ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 271 ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 272 ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 273 ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 274 ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 275 ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 276 ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 277 ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 278 ROE: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 279 ROE: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 280 ROE: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 281 ROE: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 282 ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 283 ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 284 ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 285 ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 286 ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 287 ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 288 ROE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 289 ROE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4 ASIA PACIFIC
TABLE 290 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 291 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 292 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 293 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 294 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 295 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 296 ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 297 ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 298 ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 299 ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 300 ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 301 ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 302 ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 303 ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 304 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 305 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 306 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 307 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 308 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 309 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 310 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 311 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Presence of a well-developed healthcare system to support market growth in Japan
TABLE 312 JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 313 JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 314 JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 315 JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 316 JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 317 JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 318 JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 319 JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 320 JAPAN: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 321 JAPAN: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 322 JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 323 JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 324 JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 325 JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 326 JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 327 JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 328 JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 329 JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 330 JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 331 JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Rising healthcare expenditure to drive the market growth
TABLE 332 CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 333 CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 334 CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 335 CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 336 CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 337 CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 338 CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 339 CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 340 CHINA: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 341 CHINA: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 342 CHINA: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 343 CHINA: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 344 CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 345 CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 346 CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 347 CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 348 CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 349 CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 350 CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 351 CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing healthcare sector in the country to drive market growth
TABLE 352 INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 353 INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 354 INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 355 INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 356 INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 357 INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 358 INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 359 INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 360 INDIA: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 361 INDIA: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 362 INDIA: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 363 INDIA: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 364 INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 365 INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 366 INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 367 INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 368 INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 369 INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 370 INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 371 INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 372 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 373 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 374 ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 375 ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 376 ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 377 ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 378 ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 379 ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 380 ROAPAC: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 381 ROAPAC: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 382 ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 383 ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 384 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 385 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 386 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 387 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 388 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 389 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 390 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 391 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 392 ROW: ANATOMIC PATHOLOGY MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 393 ROW: ANATOMIC PATHOLOGY MARKET, BY REGION, 2020-2025 (USD MILLION)
TABLE 394 ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 395 ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 396 ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 397 ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 398 ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 399 ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 400 ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 401 ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 402 ROW: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 403 ROW: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 404 ROW: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 405 ROW: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 406 ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 407 ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 408 ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 409 ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 410 ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 411 ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 412 ROW: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 413 ROW: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.5.1 LATIN AMERICA
9.5.1.1 Cancer screening programs to support market growth
TABLE 414 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 415 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 416 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 417 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 418 LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 419 LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 420 LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 421 LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 422 LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 423 LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 424 LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 425 LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 426 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 427 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 428 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 429 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 430 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 431 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 432 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 433 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
9.5.2 MIDDLE EAST & AFRICA
9.5.2.1 Increasing incidence of cancer in Africa to support market growth
TABLE 434 MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2019 (USD MILLION)
TABLE 435 MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION)
TABLE 436 MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 437 MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 438 MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 439 MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 440 MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 441 MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 442 MEA: ANTIBODIES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 443 MEA: ANTIBODIES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 444 MEA: KITS & REAGENTS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 445 MEA: KITS & REAGENTS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 446 MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
TABLE 447 MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
TABLE 448 MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2019 (USD MILLION)
TABLE 449 MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2020-2025 (USD MILLION)
TABLE 450 MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2019 (USD MILLION)
TABLE 451 MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2020-2025 (USD MILLION)
TABLE 452 MEA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 453 MEA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2020-2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
FIGURE 25 KEY DEVELOPMENTS IN THE ANATOMIC PATHOLOGY MARKET BETWEEN 2017 AND 2020
10.2 MARKET SHARE ANALYSIS, 2019
FIGURE 26 ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, BY INSTRUMENT AND CONSUMABLE PROVIDER, 2019
10.3 COMPETITIVE SCENARIO
10.3.1 AGREEMENTS & PARTNERSHIPS (2017-2020)
10.3.2 EXPANSIONS (2017-2020)
10.3.3 PRODUCT LAUNCHES & APPROVALS (2017-2020)
10.3.4 ACQUISITIONS (2017-2020)
10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
10.4.1 VENDOR INCLUSION CRITERIA
10.4.2 VISIONARY LEADERS
10.4.3 INNOVATORS
10.4.4 DYNAMIC DIFFERENTIATORS
10.4.5 EMERGING COMPANIES
FIGURE 27 ANATOMIC PATHOLOGY MARKET COMPETITIVE LEADERSHIP MAPPING
11 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
11.1 F. HOFFMAN-LA ROCHE LTD.
FIGURE 28 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2019)
11.2 DANAHER CORPORATION
FIGURE 29 DANAHER: COMPANY SNAPSHOT (2019)
11.3 PHC HOLDINGS CORPORATION
11.4 ABCAM PLC.
FIGURE 30 ABCAM PLC.: COMPANY SNAPSHOT (2019)
11.5 HOLOGIC, INC.
FIGURE 31 HOLOGIC, INC.: COMPANY SNAPSHOT (2019)
11.6 AGILENT TECHNOLOGIES
FIGURE 32 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
11.7 BECTON, DICKINSON AND COMPANY
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
11.8 SAKURA FINETEK USA INC.
11.9 MERCK KGAA
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2019)
11.10 BIO SB
11.11 BIOGENEX
11.12 MILESTONE MEDICAL
11.13 HISTO-LINE LABORATORIES
11.14 DIAPATH S.P.A.
11.15 SLEE MEDICAL GMBH
11.16 AMOS SCIENTIFIC PTY LTD
11.17 MEDITE MEDICAL GMBH
11.18 CELL SIGNALING TECHNOLOGY
11.19 CELLPATH LTD.
11.20 JINHUA YIDI MEDICAL APPLIANCE CO. LTD
11.21 MICROS AUSTRIA
11.22 SCILAB CO LTD
11.23 LUPETEC
11.24 MEDIMEAS
11.25 BRIGHT INSTRUMENTS
*Business overview, Products offered, Recent developments, , MNM view might not be captured in case of unlisted companies.
12 ADJACENT MARKET
12.1 INTRODUCTION
12.2 IN VITRO DIAGNOSTICS MARKET
12.2.1 MARKET DEFINITION
12.2.2 LIMITATIONS
12.2.3 MARKET OVERVIEW
12.2.3.1 INTRODUCTION
12.2.3.2 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases
12.2.3.3 Growing awareness regarding personalized medicine
12.3 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
TABLE 454 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
12.3.1 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
TABLE 455 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
12.3.2 IN VITRO DIAGNOSTICS MARKET, BY END USER
TABLE 456 GLOBAL INVITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
12.4 IN VITRO DIAGNOSTICS MARKET, BY REGION
TABLE 457 GLOBAL IN VITRO DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
13 APPENDIX
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the anatomic pathology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the anatomic pathology market. The secondary sources used for this study include the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Cancer Society (ACS), Organisation for Economic Co-operation and Development (OECD), European Centre for Disease Prevention and Control (ECDC), National Society for Histotechnology (NSH), Association of Anatomical Pathology Technology, Annual Reports, Press Releases, SEC Filings, and Investor Presentations. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the anatomic pathology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the anatomic pathology market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the anatomic pathology market on the basis of product & service, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, challenges, opportunities, and trends)
- To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the overall anatomic pathology market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World (RoW)
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, new product launches, expansions, agreements, partnerships, collaborations, and R&D activities in the anatomic pathology market.
Get in-depth analysis of the COVID-19 impact on the Anatomic Pathology Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Anatomic Pathology Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Anatomic Pathology Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Anatomic Pathology Market